David Alderdice - Concepedia

Author

David Alderdice

University of Oxford

Also Known As

D ALDERDICE, D Alderdice, D K Alderdice, D. Alderdice, D.K. Alderdice, David Alderdice

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Oxford Nottingham University Hospitals NHS Trust University of Nottingham King's College London University of Bristol

About

David Alderdice is an author at University of Oxford specializing in medicine, covid-19, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	971
2	Hospital Medicine	1	1	555
3	Pathology	1	1	11
4	Pharmacology	1	1	23
5	Antibiotics	1	1	555

David Alderdice

Publications

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31
Vasoactive Intestinal Polypeptide and Phentolamine Mesylate Administered by Autoinjector in the Treatment of Patients With Erectile Dysfunction Resistant to Other Intracavernosal Agents W W Dinsmore, David Alderdice The Journal of Urology Molecular PharmacologyUrologyVoiding DysfunctionErectile DysfunctionVasoactive Intestinal Polypeptide	1998	23
A family with Fabry disease diagnosed by a single angiokeratoma Andrea Corry, Clióna Feighery, David Alderdice, Dermatology Online Journal Fabry DiseaseEnzyme Replacement TherapyPathologyDermatologySingle Angiokeratoma	2011	11
Efficacy of topical PUVA soaks for palmoplantar dermatoses: an audit Donal O’Kane, Nabla McLoone, Hilary Jenkinson, Photodermatology Photoimmunology & Photomedicine	2008	10

Page 1